Business Context and Reporting Period
This Form 6-K filing by GSK plc (GSK) reports a transaction in the company's own shares. The filing date is December 10, 2025, covering a share repurchase executed on December 9, 2025. The transaction was conducted through BNP Paribas SA as part of GSK's existing non-discretionary buyback programme announced on September 30, 2025.
Key Financial Metrics and Transaction Details
The filing details a specific block of share repurchases rather than full-period financial results. Key metrics for the December 9, 2025 transaction include:
- Shares Purchased: 250,000 ordinary shares of 31½ pence each.
- Price Range: Lowest price paid was 1,780.00 GBp; highest price paid was 1,820.00 GBp.
- Average Price: Volume-weighted average price paid was 1,800.43 GBp.
- Trading Venues: Purchases were executed across BATE, CHIX, and XLON (London Stock Exchange).
Since the programme's inception on September 30, 2025, GSK has purchased a total of 12,724,733 ordinary shares. Following this transaction, the company holds 238,189,577 shares in treasury. The total number of ordinary shares in issue (excluding treasury shares) is 4,077,249,560.
Material Changes and Capital Structure
The primary material change reported is the reduction in outstanding shares and the increase in treasury holdings. The percentage of voting rights attributable to ordinary shares held in treasury is now 5.84%. The total number of voting rights in the company remains 4,077,249,560. This filing does not report changes in revenue, profit, cash flow, or debt levels, as it is a disclosure of a capital transaction.
Guidance, Outlook, and Risks
The filing contains no new financial guidance or management commentary regarding operational outlook. It includes a standard cautionary statement regarding forward-looking statements, noting that actual results may differ materially from projections due to risks described in GSK's 2024 Annual Report on Form 20-F and Q3 2025 results. No specific new contingencies or unusual items were disclosed in this document.
Key Facts for Investor Verification
- Verify the total cumulative buyback volume of 12,724,733 shares since September 30, 2025.
- Confirm the updated treasury share count of 238,189,577 and the resulting 5.84% voting rights held in treasury.
- Note the share price range of 1,780.00p to 1,820.00p during the execution of this specific block trade.
- Review the non-discretionary agreement terms announced on September 30, 2025, to understand the remaining capacity of the buyback programme.